University of Wisconsin School of Medicine and Public Health
Dr. Jacques Galipeau is a leading expert in cell therapy, particularly in the use of mesenchymal stromal cells (MSCs). As a Professor of Oncology and Director of the Advanced Cell Therapy Program at the University of Wisconsin, he brings extensive experience in developing and translating cell-based therapies from bench to bedside. Dr. Galipeau serves as a valuable advisor, providing invaluable guidance on GMP facility management for the production of clinical-grade MSCs and navigating the complexities of clinical studies involving MSCs, ensuring rigorous and effective research.
Qualification
MD FRCP(C)
Title and Affiliation
Don and Marilyn Anderson Professor in Oncology
Associate Dean for Therapeutics Development
University of Wisconsin School of Medicine and Public HealthUniversity of Wisconsin in Madison
Brief Description of Collaboration
Dr. Jacques Galipeau is a leading expert in cell therapy, particularly in the use of mesenchymal stromal cells (MSCs). As a Professor of Oncology and Director of the Advanced Cell Therapy Program at the University of Wisconsin, he brings extensive experience in developing and translating cell-based therapies from bench to bedside. Dr. Galipeau serves as a valuable advisor, providing invaluable guidance on GMP facility management for the production of clinical-grade MSCs and navigating the complexities of clinical studies involving MSCs, ensuring rigorous and effective research.
Email: [email protected]
Link: https://www.medicine.wisc.edu/directory/galipeau_jacques